| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.44M | — |
| Operating expense | — | — |
| Net income | -31.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SGMOQ returned -76.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -66.7% |
| 1 year | -76.3% |
| 5 years | -98.5% |
| 10 years | -96.6% |
| All-time high | $49.25 (Aug 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SGMOQ would be worth today ›No. Sangamo Therapeutics, Inc. has not paid a dividend in the past 12 months.
Sangamo Therapeutics, Inc. is part of the Healthcare sector.
Sangamo Therapeutics, Inc. has a market cap of 60.61M USD, based on the latest quote.